Putting patients first: It's in our blood.
At Guardant Health, we are dedicated to helping patients at all stages of cancer live longer and healthier lives through the power of our blood tests and the insights they unlock. Our tests help patients at every step in the cancer journey, from screening—to detect cancer early, when it is most treatable—to identifying residual and recurring disease in patients with early-stage disease and informing treatment decisions in patients with advanced-stage disease.
We're here to listen
Patients are at the heart of our mission and they are the inspiration behind what drives us every day. By connecting with patients and caregivers, we gain insights into the challenges they face at all stages of the journey. Hearing patients’ stories and experiences enables us to make sure we are directly addressing unmet needs in meaningful ways. And sharing these stories enables us to inspire, motivate, and support other patients along the way.
At Guardant Health, we strongly believe in the power of partnership. Here is just a small snapshot of some of our recent work:
Supporting the creation of the Colon Cancer Coalition’s Survivorship Council
We were pleased to support the 2022 launch of the Colon Cancer Coalition’s first Survivorship Council, inclusive of 17 patients, survivors, and caregivers impacted by colorectal cancer, brought together for not only connection and support, but to share their unique perspectives and help inform and improve future awareness and educational efforts in the colorectal cancer treatment and screening space.
Read more on coloncancercoalition.org
Partnering with Susan G. Komen® to develop clinical studies - with an emphasis on uplifting the patient perspective
We've partnered with Susan G. Komen®, the world’s leading breast cancer organization, to develop clinical studies designed to help identify patients with early-stage breast cancer who may benefit from additional monitoring or therapy. A critical element of this partnership is the use of input from patient advocates to guide the research study design -- the Susan G. Komen Advocates in Science will provide first-hand perspective of what matters most to patients. Our collaboration with Susan G. Komen will help researchers understand the value of monitoring for residual or recurring disease in patients treated for breast cancer with the Guardant Reveal™ blood test and aligns with our patient-centered approach.
Read more on Komen.org
Raising awareness of the importance of screening for colorectal cancer in partnership with Fight CRC
With approximately 150,000 new cases of colorectal cancer (CRC) diagnosed each year1 – and it is expected to be the #1 cancer killer of people under 50 by the year 20302 – spreading the word about the value of screening is more critical than ever. In honor of Colorectal Cancer Awareness Month in March, we collaborated with Fight CRC on the development and production of a public service announcement, using real patients and people impacted by the disease to educate others on when to screen, how to screen, and to encourage them to take action with their health.
Watch our video .
Our research and products
Bringing innovation to the field of cancer care is only possible with strong patient engagement. We are proud to partner with patients to help inform our study designs and to get groundbreaking and quality research underway with leading investigators at medical centers and biopharmaceutical companies to help transform how cancer is detected, treated, and managed.
If you are interested in participating in a study, or you would like to learn more about the breadth and progress of our expanding research, you can view our Clinical Studies. And if you’d like to explore our current product portfolio and see what we are offering patients today, please browse our products.
Our commitment to access
We believe all patients deserve access to the healthcare they need. Our Guardant Access program helps patients navigate insurance eligibility, manage claims appeals, answer billing questions, and determine financial assistance eligibility for our tests.
To learn more about how Guardant Access may be able to help you, please contact our Client Services Team:
For Oncology Support:
For Shield™ support:
Phone: 1.855.722.7335, ext. 1, then press 2
If you’d like to discuss a possible collaboration, learn more about our patient advocacy initiatives, or share your story, please contact our Patient Advocacy Team at firstname.lastname@example.org.